466.65

-0.68%↓

SANES

9.719

-0.61%↓

SAF

283.2

-1.5%↓

BBVA

18.85

+0.94%↑

BNP

83.35

+0.45%↑

466.65

-0.68%↓

SANES

9.719

-0.61%↓

SAF

283.2

-1.5%↓

BBVA

18.85

+0.94%↑

BNP

83.35

+0.45%↑

466.65

-0.68%↓

SANES

9.719

-0.61%↓

SAF

283.2

-1.5%↓

BBVA

18.85

+0.94%↑

BNP

83.35

+0.45%↑

466.65

-0.68%↓

SANES

9.719

-0.61%↓

SAF

283.2

-1.5%↓

BBVA

18.85

+0.94%↑

BNP

83.35

+0.45%↑

466.65

-0.68%↓

SANES

9.719

-0.61%↓

SAF

283.2

-1.5%↓

BBVA

18.85

+0.94%↑

BNP

83.35

+0.45%↑

Strona główna・Stock List・Synergie SA.

Synergie SA.

Open

26.6 -2.92

Buy Sell

Overview

Share price change

24h

Current

Min

26.6

Max

27.9

Key metrics
By Trading Economics
Income	27M
Sales	1.6B
P/E Sector Avg	9.925 55.155
Dividend yield	1.9
Profit margin	1.718
Employees	5,350
EBITDA	14B

Dividends
By Dow Jones
Dividend yield Sector Avg	1.90% 4.95%

Market Stats
By TradingEconomics
Market Cap	603M
Previous open	29.52
Previous close	26.6

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

30.5 / N/A Support & Resistance

Synergie SA. Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 kwi 2026, 23:17 UTC

Earnings

Samsung Forecasts Record First-Quarter Operating Profit

6 kwi 2026, 23:00 UTC

Hot Stocks

Stocks to Watch: Health Insurers, Mawson, Owlet

6 kwi 2026, 22:13 UTC

Major Market Movers

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 kwi 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 kwi 2026, 17:09 UTC

Major Market Movers

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 kwi 2026, 16:56 UTC

Major News Events

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 kwi 2026, 14:47 UTC

Major Market Movers

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 kwi 2026, 00:00 UTC

Major News Events

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 kwi 2026, 23:58 UTC

Market Talk

Major News Events

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 kwi 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 kwi 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 kwi 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 kwi 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 kwi 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 kwi 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 kwi 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 kwi 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 kwi 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 kwi 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 kwi 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 kwi 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 kwi 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 kwi 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 kwi 2026, 18:36 UTC

Acquisitions, Mergers, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 kwi 2026, 17:59 UTC

Market Talk

Major News Events

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 kwi 2026, 17:13 UTC

Acquisitions, Mergers, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 kwi 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 kwi 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 kwi 2026, 14:59 UTC

Earnings

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Peer Comparison

Price change

Synergie SA. Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Synergie SA. - Dist in the past 3 months.

Technical Score

By Trading Central

30.5 / N/ASupport & Resistance

Recent bullish events outweigh bearish events.

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Synergie SA.

Synergie SE provides human resources management and development services for companies and institutions in France, Belgium, Other Northern and Eastern Europe, Italy, Spain, Portugal, Canada, and Australia. It offers temporary work, recruitment, out-placement, social engineering, consultancy, and training services. The company serves various specialized sectors and industries, such as renewable energy, transport and logistics, construction and public works, healthcare, agri-food, and tertiary sectors. Synergie SE was founded in 1969 and is headquartered in Paris, France.